The data collected based on
5
patient reviews on Google
Certificates
Features & Facts
Specialized cancer immunotherapies
The clinic has a deep focus on dendritic cell-based immunotherapy, a cutting-edge treatment that harnesses the body’s own immune system to fight cancer. This treatment involves collecting a patient’s monocytes, differentiating them into antigen-presenting dendritic cells, and "training" them to recognize and target cancer cells.
First active specific immunotherapy (ASI)
Using antigen-enhanced tumor lysates in ovarian cancer patients was developed in 1984 at the University Women’s Clinic in Göttingen by Dr. T. Neßelhut.
Institute for Tumor Therapy
The institute was founded in 1996 by Dr. Neßelhut to further develop and research immunotherapy applications.
Manufacturing certification
In 2012, the clinic received a personal manufacturing license for somatic cell therapeutics under Germany's Medicines Act, enabling them to produce and dispense cutting-edge cellular therapies directly for patient use.
Research and innovation
The clinic's medical team has contributed to the scientific community through various publications and conference presentations, sharing their research findings and clinical experiences in the field of immunotherapy. From 2005-2010, the clinic was actively involved in funding research projects, supported by the Society for Biological Cancer Defense, the Research Center Jülich GmbH, and the European Fund for Regional Development.
Unique procedures & specialized services
The clinic offers dendritic cell-based immunotherapy, utilizing the patient's own immune cells to target cancer cells. In the laboratory, collected monocytes are differentiated into dendritic cells and prepared for reintroduction into the patient's body.
Complementary therapies
The Practice Group for Cell Therapy Duderstadt provides supportive therapies tailored to individual patient needs, integrating both conventional and complementary medical approaches to enhance overall treatment efficacy.
Experienced team
The practice boasts a multidisciplinary team of experienced physicians and laboratory specialists committed to providing personalized patient care. The clinic’s practice group has grown since its founding and now includes a network of specialists such as Dr. J. Neßelhut, Dr. M. Martin, and Dr. K. Briken, enhancing the clinic’s capacity for diverse treatment options.
Advanced laboratory techniques
In the laboratory, collected monocytes are differentiated into dendritic cells and prepared for reintroduction into the patient's body. In 2011, the clinic expanded its capabilities with the commissioning of a new clean room laboratory, equipped to handle complex cell therapies. The clinic's laboratory team supports the preparation and development of cell-based therapies, maintaining high standards of quality and safety.
Comprehensive diagnostic assessments
The Practice Group for Cell Therapy Duderstadt conducts thorough diagnostic assessments, including blood work and imaging studies, to gather detailed information about the patient's condition.
Advancing medical science
The clinic's medical team has contributed to the scientific community through various publications and conference presentations, sharing their research findings and clinical experiences in the field of immunotherapy.
Integration of research in practice
The clinic’s team has contributed significantly to the field of dendritic cell immunotherapy, publishing numerous articles and presenting at international conferences such as ASCO and CIMT.
Pioneering immunotherapy publications
Several book chapters and research papers have been published, particularly on dendritic cell therapy in treating cancers like glioblastoma and melanoma.
Focus on dendritic cell therapy
At the heart of the clinic’s offerings is dendritic cell therapy, an advanced and personalized form of immunotherapy. It specializes in advanced immunotherapy techniques, including cancer vaccines, to treat various diseases.
Immune system focus
The clinic offers therapies aimed at enhancing the immune system's effectiveness in combating diseases.
Holistic approach
The clinic emphasizes a holistic approach, considering both the physical and psychological aspects of patient care.
Personalized Treatment Plans
Based on diagnostic results, a customized treatment plan is developed, outlining the type and course of immunotherapy to be administered.
Regular follow-Up care
Regular follow-up appointments are scheduled to monitor the patient's response to therapy and make any necessary adjustments to the treatment plan.
About the clinic
The Practice Group for Cell Therapy Duderstadt, located in Duderstadt, Germany, is a cutting-edge medical clinic specializing in innovative cell-based therapies, particularly for cancer treatment. Established with a mission to harness the body’s immune system against severe illnesses, the clinic has developed a reputation for excellence in dendritic cell therapy and personalized medicine. The clinic integrates the latest advancements in immunotherapy research with state-of-the-art clinical practice to provide holistic and effective care. Its commitment to innovation and patient well-being places it among the leading centers for cell-based treatments in Europe. The Practice Group for Cell Therapy Duderstadt offers a welcoming environment designed to maximize patient comfort and treatment efficacy. Its modern facility includes advanced laboratories for the preparation of dendritic cell vaccines, spacious treatment rooms equipped with cutting-edge medical technologies, and thoughtfully designed consultation spaces to ensure privacy and personalized care. The clinic’s infrastructure is meticulously maintained to support its rigorous clinical and laboratory processes. Every aspect of the facility reflects the clinic’s dedication to excellence in patient care and safety. The practise is home to a team of highly qualified physicians, scientists, and technical staff specializing in immunotherapy and oncology. The multidisciplinary team collaborates closely to design and implement personalized treatment protocols tailored to each patient’s unique needs. Their expertise extends beyond clinical care to active involvement in research and scientific publications, contributing to advancements in the field of immunotherapy. The team’s commitment to evidence-based medicine ensures patients receive the most effective and safe treatments. At the heart of the clinic’s offerings is dendritic cell therapy, an advanced and personalized form of immunotherapy. This involves extracting a patient’s immune cells, enhancing them in a laboratory, and reintroducing them to stimulate the body’s natural defense mechanisms against cancer. The clinic also provides complementary therapies to enhance immune system performance and improve the patient’s overall health and well-being. These supportive treatments aim to address physical, emotional, and psychological aspects of the healing process. Practice Group for Cell Therapy emphasizes a patient-centered approach, ensuring that care is tailored to individual needs. Patients undergo a comprehensive evaluation during the initial consultation to determine their suitability for immunotherapy. This is followed by detailed diagnostic assessments, including blood tests and imaging studies. Based on these findings, a personalized treatment plan is developed. Each stage of the treatment journey, from monocyte extraction to dendritic cell administration, is carefully managed to optimize outcomes. The clinic also provides regular follow-up care to monitor progress and make necessary adjustments to the therapy plan. The clinic is deeply committed to advancing the science of immunotherapy. Its team actively participates in clinical research and contributes to medical literature. These efforts ensure that the treatments offered are aligned with the latest scientific discoveries, providing patients access to cutting-edge therapeutic options. Practice Group for Cell Therapy Duderstadt, Germany was founded on the belief that the body’s immune system holds the key to fighting complex diseases. Over the years, the clinic has established itself as a leader in the field of cell-based therapy, blending innovative medical techniques with compassionate care. The clinic envisions a future where immunotherapy continues to revolutionize cancer treatment, offering hope and healing to patients worldwide. It remains steadfast in its mission to improve lives through pioneering medical care, research, and education.
dendritic cells, oncology, cancer vaccines, immunotherapy, cell-based therapies, gynaecological oncology
Cell laboratory
Gallery
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
2025-01-11T08:33:34.000Z
Dendritic Cells Cancer Treatment Germany - Raquel Abreu
2025-01-11T08:16:10.000Z
Dendritic Cells Cancer Treatment Germany - Raquel Abreu
Ralph Steinman, Nobel prize winner, speaks about dendritic cells and immune-based vaccines
2025-01-11T08:15:57.000Z
Ralph Steinman, Nobel prize winner, speaks about dendritic cells and immune-based vaccines
Extra services
Visa Support
Telemedicine
Parking Space
Location
Hinterstraße 53, 37115 Duderstadt, Germany
FAQ
What is dendritic cell immunotherapy?
Dendritic cell immunotherapy is a form of personalized cancer treatment where the patient’s own immune cells (dendritic cells) are trained to recognize and attack cancer cells. The cells are modified in a laboratory and then reintroduced to the patient to stimulate a targeted immune response.
How does the treatment process work?
The process begins with a blood draw or leukapheresis to collect monocytes. These are then cultured and stimulated to develop into dendritic cells. After 7 days of preparation, the activated dendritic cells are reintroduced to the patient through a vaccination-like procedure.
Which cancers can be treated with dendritic cell immunotherapy?
This therapy can be used for a variety of cancers, including melanoma, glioblastoma, prostate cancer, and ovarian cancer, among others. It’s especially beneficial in cases where traditional treatments are less effective.
Is dendritic cell therapy suitable for all patients?
Dendritic cell therapy is typically tailored to each patient’s unique cancer type and condition. It is generally suitable for patients who have advanced cancer or who have not responded well to conventional treatments.
What are the side effects of immunotherapy?
The side effects of dendritic cell therapy are typically mild and can include fever, fatigue, pain at the injection site, and occasionally mild flu-like symptoms as the immune system activates. Severe side effects are rare.
How long does the treatment take?
The treatment typically takes 7 days to prepare the dendritic cells in the laboratory. Afterward, patients typically undergo injections over several weeks to maximize the immune response.
Is this treatment covered by insurance?
The clinic suggests consulting your insurance provider regarding coverage for dendritic cell immunotherapy. Many insurances refuse to cover dendritic cells. As a specialized treatment, coverage may vary depending on the insurer.
Are there any clinical trials available?
Yes, the clinic is involved in ongoing research and may offer patients access to clinical trials focused on immunotherapy and cancer treatment. It’s recommended to inquire with the clinic about current trial opportunities.
What is the rating of the clinic?
Practice Group for Cell Therapy Duderstadt is rated as 9.70 by AiroMedical.
What do patients say about Practice Group for Cell Therapy Duderstadt?
The clinic has 5 feedbacks at other places. The UserScore of the hospital is 95%.
What is the primary focus of the hospital?
The medical center is an expert at cancer, dendritic, pregnancy, immunotherapy, and oncology.